MBX

MBX Biosciences, Inc.

NasdaqHealthcarePHARMACEUTICAL PREPARATIONS

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$288k2 sales
Net open-market−$288kBuying minus selling
Active insiders3Distinct reporting owners

MBX transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Hoerter Steven L.
Chair · President
CHAIR, PRES
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$268kView disclosure →
Azoulay Salomon
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$20.1kView disclosure →
Radovich Peter
Director
DIR
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 12, 2026

Open-market transaction mix · 2 transactions in the selected period
0 buys0%·100%2 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026001$0$0$0
Nov 2026020$0$288,361.34−$288,361.34

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (2)
Oct 2026: 1 insidersNov 2026: 2 insiders
Oct 2026Nov 2026
3distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
3 insiders
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 3 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale$268k
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
3transactionstxns
  • S · Open-market sells · dominant2 · 67%
  • A · Grants / awards1 · 33%

Activity by reported role

A joint filing can contribute to multiple roles
CHAIR1
CMO1
Director1
PRES1

Reported Holdings After

Separated by insider, security, and ownership type

Radovich PeterStock option (right to buy) · Direct
18.2k18.2kOct 20, 2026Oct 20, 2026
18,200Oct 20, 2026
Azoulay SalomonCommon Stock · Direct
14.0k14.0kNov 4, 2026Nov 4, 2026
14,026Nov 4, 2026
Hoerter Steven L.Common Stock · Direct
78.0k78.0kNov 10, 2026Nov 10, 2026
78,045Nov 10, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
3 active days
Oct 16 → Nov 16
LessMore

MBX Biosciences, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at MBX Biosciences, Inc.?

Hoerter Steven L., Azoulay Salomon, Radovich Peter.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Hoerter Steven L. reported a sale on Nov 10, 2026 valued at $268k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $288,361.34. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.